alexa Ex Vivo DNA Damage Response Assays In Tumor Slices To Predict Therapy Response
ISSN: 2161-1025

Translational Medicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Translational & Personalized Medicine
August 05-07, 2013 Holiday Inn Chicago-North Shore, IL, USA

Dik C. Van Gent
ScientificTracks Abstracts: Transl Med
DOI: 10.4172/2161-1025.S1.008
Abstract
One of the hallmarks of cancer is genomic instability, which has been studied extensively in tumor cell lines. It has been much more difficult to study how DNA damage response (DDR) pathways operate in living tumors. Therefore, we developed several techniques to grow short term tumor cell cultures or tumor slices ? ex vivo ? and study the DDR by inducing DNA damage in cultured tumor cells or slices. Several DNA repair proteins accumulate as visible foci on DNA double strand breaks (DSBs). We used this phenomenon to study accumulation of the general markers of DNA breaks (gamma-H2AX and 53BP1) and the homologous recombination repair pathway (RAD51) after DSB induction. BRCA1 or BRCA2 deficiency has been shown before to lead to a defect in RAD51 foci formation. We were able to show that BRCA1 deficient and proficient xenograft tumors could be discriminated well on the basis of this assay. We also screened human tumors and found that a BRCA1 deficient tumor metastasis was RAD51 foci deficient, while most sporadic tumors were proficient. Interestingly, we were also able to identify a sporadic tumor that was RAD51 foci deficient. This tumor slice also showed high sensitivity to PARP inhibitor treatment, another hallmark of BRCA1/2 deficient cells. Therefore, we conclude that we developed a robust assay for identifying BRCA-deficient tumors, which will be important to select patients for PARP inhibitor treatment. Furthermore, other therapeutic interventions can also be tested in this system, which maintains tumor slice integrity and proliferation for at least one week.
Biography
Dik C. Van Gent did his Ph.D. at the Netherlands Cancer Institute (NKI) and postdoctoral studies at the National Institutes of Health (USA). He is now Associate Professor at the world-renowned DNA repair group at the Department of Genetics of the Erasmus MC Rotterdam, one of the largest university medical centers in The Netherlands. He has published more than 50 papers in reputed journals, including Cell, Science and Nature and serves as an editorial board member of ?DNA Repair? and ?Genome Integrity?.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version